156 related articles for article (PubMed ID: 37876483)
1. HOXC10 promotes esophageal squamous cell carcinoma progression by targeting FOXA3 and indicates poor survival outcome.
He X; Wang H; Wang R; Li Y; Li S; Cao X; Xu J
Heliyon; 2023 Oct; 9(10):e21056. PubMed ID: 37876483
[TBL] [Abstract][Full Text] [Related]
2. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis.
Suo D; Wang Z; Li L; Chen Q; Zeng T; Liu R; Yun J; Guan XY; Li Y
Oncogene; 2020 Aug; 39(32):5441-5454. PubMed ID: 32587398
[TBL] [Abstract][Full Text] [Related]
3. HOXC10 promotes migration and invasion via the WNT-EMT signaling pathway in oral squamous cell carcinoma.
Dai BW; Yang ZM; Deng P; Chen YR; He ZJ; Yang X; Zhang S; Wu HJ; Ren ZH
J Cancer; 2019; 10(19):4540-4551. PubMed ID: 31528218
[TBL] [Abstract][Full Text] [Related]
4. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA GK-IT1 promotes esophageal squamous cell carcinoma by regulating MAPK1 phosphorylation.
Yang X; Zeng T; Liu Z; He W; Hu M; Tang T; Chen L; Xing L
Cancer Med; 2022 Dec; 11(23):4555-4574. PubMed ID: 35608100
[TBL] [Abstract][Full Text] [Related]
6. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
7. KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling.
Hao WW; Xu F
World J Gastrointest Oncol; 2022 Jul; 14(7):1239-1251. PubMed ID: 36051093
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
[TBL] [Abstract][Full Text] [Related]
9. High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Feng Y; Yan S; Huang Y; Huang Q; Wang F; Lei Y
BMC Cancer; 2020 Jun; 20(1):602. PubMed ID: 32600359
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.
Wang Y; Lyu Z; Qin Y; Wang X; Sun L; Zhang Y; Gong L; Wu S; Han S; Tang Y; Jia Y; Kwong DL; Kam N; Guan XY
Theranostics; 2020; 10(25):11535-11548. PubMed ID: 33052231
[No Abstract] [Full Text] [Related]
13. Upregulated forkhead-box A3 elevates the expression of forkhead-box A1 and forkhead-box A2 to promote metastasis in esophageal cancer.
Chen B; Yu J; Lu L; Dong F; Zhou F; Tao X; Sun E
Oncol Lett; 2019 May; 17(5):4351-4360. PubMed ID: 30944629
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway.
Guan Y; He Y; Lv S; Hou X; Li L; Song J
J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
17. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
[TBL] [Abstract][Full Text] [Related]
19. METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Li J; Li Z; Xu Y; Huang C; Shan B
J Cancer; 2022; 13(6):1972-1984. PubMed ID: 35399719
[No Abstract] [Full Text] [Related]
20. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]